The Non-Dipping Blood Pressure Phenotype Is Independently Linked to Systemic Inflammation and Atherogenic Burden

Mert Deniz Savcilioglu1, Kemal Ozan Lule2, Yunus Cakalli1

  • 1Cardiology Department, Faculty of Medicine, Gaziantep University, Gaziantep 27410, Türkiye.

Insights

A non-dipping blood pressure pattern, linked to cardiovascular risk, is associated with both systemic inflammation and atherogenic burden in individuals without metabolic disease. These factors may offer biological insights into abnormal circadian blood pressure regulation.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Circadian Biology

Background:

  • Non-dipping blood pressure, an insufficient nocturnal systolic decline, elevates cardiovascular risk and target organ damage.
  • While metabolic issues affect circadian blood pressure, the roles of systemic inflammation and atherogenic burden in non-metabolic disease populations are unclear.
  • This study investigates the association of systemic inflammatory response index (SIRI) and atherogenic index of plasma (AIP) with nocturnal blood pressure patterns.

Purpose of the Study:

  • To evaluate the association of SIRI and AIP with nocturnal blood pressure patterns in adults without overt metabolic disease.
  • To determine if inflammatory and atherogenic markers independently predict non-dipping blood pressure.
  • To assess the combined discriminative performance of these markers in identifying non-dipping patterns.

Main Methods:

  • A retrospective cross-sectional study of 469 adults undergoing 24-hour ambulatory blood pressure monitoring (ABPM).
  • Participants classified as dippers (≥10% nocturnal systolic BP decline) or non-dippers (<10%).
  • Hierarchical logistic regression and ROC analysis used to assess associations and discriminative performance of SIRI, AIP, and fasting glucose.

Main Results:

  • Non-dipping was observed in 62.5% of participants.
  • Non-dippers had higher LDL cholesterol, AIP, and SIRI compared to dippers.
  • AIP and SIRI were independently associated with non-dipping blood pressure, increasing model explanatory power. Age and fasting glucose also remained significant.

Conclusions:

  • Both systemic inflammation (SIRI) and atherogenic burden (AIP) are associated with the non-dipping blood pressure pattern in individuals without overt metabolic disease.
  • These markers, particularly when assessed together, may provide valuable biological insights into the mechanisms of circadian blood pressure dysregulation.
  • While individual marker discrimination was modest, the multivariable model showed improved predictive capability for non-dipping status.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
64.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
742